Free Trial
NASDAQ:HIT

Health In Tech (HIT) Stock Price, News & Analysis

Health In Tech logo
$1.18 +0.08 (+7.27%)
As of 12:40 PM Eastern

About Health In Tech Stock (NASDAQ:HIT)

Key Stats

Today's Range
$1.09
$1.23
50-Day Range
$0.58
$1.13
52-Week Range
$0.51
$7.59
Volume
436,698 shs
Average Volume
1.19 million shs
Market Capitalization
$64.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50
Consensus Rating
Strong Buy

Company Overview

Receive HIT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health In Tech and its competitors with MarketBeat's FREE daily newsletter.

HIT Stock News Headlines

[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Health In Tech (NASDAQ:HIT) Stock Rating Lowered by Wall Street Zen
HIT Health In Tech, Inc.
See More Headlines

HIT Stock Analysis - Frequently Asked Questions

Health In Tech's stock was trading at $5.19 at the start of the year. Since then, HIT shares have decreased by 79.0% and is now trading at $1.09.

Health In Tech, Inc. (NASDAQ:HIT) released its quarterly earnings data on Monday, April, 14th. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.02 by $0.01. The business had revenue of $8.02 million for the quarter, compared to analysts' expectations of $6.87 million.
Read the conference call transcript
.

Health In Tech (HIT) raised $9 million in an initial public offering (IPO) on the week of December 23rd 2024. The company issued 2,300,000 shares at a price of $4.00 per share. American Trust Investment Services acted as the underwriter for the IPO.

Health In Tech's lock-up period expired on Monday, June 23rd. Health In Tech had issued 2,300,000 shares in its public offering on December 23rd. The total size of the offering was $9,200,000 based on an initial share price of $4.00. Since the end of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

Shares of HIT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
4/14/2025
Today
7/17/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Insurance Agents, Brokers & Service
Sub-Industry
Insurance
Current Symbol
NASDAQ:HIT
Previous Symbol
NASDAQ:HIT
CIK
2019505
Web
N/A
Fax
N/A
Employees
79
Year Founded
N/A

Price Target and Rating

High Price Target
$2.50
Low Price Target
$2.50
Potential Upside/Downside
+127.3%
Consensus Rating
Strong Buy
Rating Score (0-4)
4.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$22.38 million
Price / Sales
2.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
54,673,000
Free Float
N/A
Market Cap
$60.14 million
Optionable
N/A
Beta
N/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:HIT) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners